Overview
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the safety of R89674 0.25% ophthalmic solution in healthy normal volunteersPhase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Vistakon PharmaceuticalsTreatments:
Ophthalmic Solutions
Criteria
Inclusion Criteria:healthy normal volunteers age >=3 years with normal ocular health and a best-corrected
logMAR score of 0.3 or better
-
Exclusion Criteria:
intraocular surgery and/or ocular surgical intervention within last 3 months, refractive
surgery within last 6 months, active ocular disorder other than refractive disorders,
breastfeeding women, pregnant female < 18 years of age -